Related Experiment Video
Updated: Dec 25, 2025
12:49
Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model
Published on: August 17, 2022
2.8K
Top Papers in Liver Transplantation 2017-2018
Isolina Baños Pérez1, Ana Duca1
1Unit Transplantation Liver, Internal Medicine Service, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain.
Transplantation Proceedings
|April 6, 2020
Summary
Liver transplant organ shortages are decreasing due to advances in donor management and hepatitis C treatment. These innovations improve patient outcomes and expand the donor pool for transplants.
Area of Science:
- Transplantation immunology
- Hepatology
- Organ donor management
Background:
- Organ shortage is a critical barrier in liver transplantation.
- Recent years have seen significant advancements in addressing this limitation.
- Improved understanding of liver immunology and rejection mechanisms is crucial.
Purpose of the Study:
- To review key research from 2017-2018 on expanding the donor pool for liver transplantation.
- To analyze the impact of new immunosuppression strategies and donor management techniques.
- To discuss the role of direct-acting antiviral agents in managing hepatitis C virus infection in transplant candidates.
Main Methods:
- Review of high-impact publications from 2017-2018.
- Analysis of advancements in donor selection and preservation (e.g., perfusion techniques).
- Evaluation of evolving immunosuppression protocols and their effect on outcomes.
Main Results:
- Advances in donor management, including perfusion technologies, have expanded the usable donor pool.
- New immunosuppressive strategies and a better understanding of antibody-mediated rejection have improved patient outcomes.
- Direct-acting antiviral agents have transformed hepatitis C virus infection management, impacting transplantation eligibility.
Conclusions:
- Innovations in donor management and immunosuppression have successfully increased liver transplant capacity.
- Improved treatment of hepatitis C virus infection has broadened the scope of potential transplant recipients.
- These combined advances are reshaping the landscape of end-stage liver disease management and organ transplantation.
